Company profile: Synlogic
1.1 - Company Overview
Company description
- Provider of synthetic biotic medicines designed to perform metabolic functions to treat diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Synlogic
Passage Bio
HQ: United States
Website
- Description: Provider of fully integrated gene therapy development focused on treatments for monogenic central nervous system diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Passage Bio company profile →
Bamboo Therapeutics
HQ: United States
Website
- Description: Provider of gene therapy development, research, and manufacturing for rare genetic diseases, advancing the work of Dr. Richard Jude Samulski at UNC’s Gene Therapy Center from the laboratory into human clinical trials to meet drug approval requirements. Operates a Sanford, North Carolina manufacturing complex using specialized methodologies and advanced techniques.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bamboo Therapeutics company profile →
Mammoth Biosciences
HQ: United States
Website
- Description: Provider of CRISPR-based diagnostics, therapeutics, and protein discovery solutions. The DETECTR Platform delivers instrument-free nucleic acid detection for disease; therapeutics offer precision genome editing using novel CRISPR-Cas enzymes; and a proprietary platform discovers new CRISPR systems and Cas proteins for applications in research, agriculture, and biodefense.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mammoth Biosciences company profile →
Epizyme
HQ: United States
Website
- Description: Provider of biopharmaceutical research and treatments focused on blood cancer and tumors. Based in Cambridge, MA and founded in 2007, the company translates epigenetic research into programs and offers Bylvay, a non-systemic ileal bile acid transport inhibitor for cholestatic pruritus in Alagille syndrome.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Epizyme company profile →
IntegenX
HQ: United States
Website
- Description: Provider of automation systems enabling reliable microsample preparation and analysis for the life sciences, including platforms for DNA sequencing and human DNA identification. Offerings include the RapidHIT ID system generating forensic DNA profiles in 90 minutes, sample cartridges for reference and crime scene samples, and RapidLINK software for centralized rapid DNA testing, matching, familial search, and kinship verification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IntegenX company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Synlogic
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Synlogic
2.2 - Growth funds investing in similar companies to Synlogic
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Synlogic
4.2 - Public trading comparable groups for Synlogic
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →